Veletri is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Epoprostenol.
Product ID | 66215-402_1bec1b5a-5956-4b0a-b46e-c85a051d1631 |
NDC | 66215-402 |
Product Type | Human Prescription Drug |
Proprietary Name | Veletri |
Generic Name | Epoprostenol |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-04-22 |
Marketing Category | NDA / NDA |
Application Number | NDA022260 |
Labeler Name | Actelion Pharmaceuticals US, Inc. |
Substance Name | EPOPROSTENOL |
Active Ingredient Strength | 2 mg/10mL |
Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-04-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022260 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-04-22 |
Ingredient | Strength |
---|---|
EPOPROSTENOL | 1.5 mg/10mL |
SPL SET ID: | df502787-46ec-4dd1-a2c0-be90f6d95a5d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
66215-402 | Veletri | epoprostenol |
66215-403 | Veletri | epoprostenol |
62756-059 | epoprostenol | epoprostenol |
62756-060 | epoprostenol | epoprostenol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VELETRI 79070519 3818540 Live/Registered |
Actelion Pharmaceuticals Ltd. 2009-06-05 |
VELETRI 77871287 not registered Dead/Abandoned |
Actelion Pharmaceuticals Ltd. 2009-11-12 |
VELETRI 76289963 2720582 Live/Registered |
Actelion Pharmaceuticals Ltd. 2001-07-25 |